Back to job listings

Associate Director, Senior Pharmacovigilance Scientist (permanent or interim contract)$ On application


Location: Boston / Cambridge, MA - USA

Type: Permanent

An established biotech organisation for a brand new role within safety.

We are currently partnered with an established biotech organisation for a brand new role within safety.


This client, work on a wide range of therapeutic areas with a strong focus on Oncology.  Following numerous product launches, they are actively looking to build their Pharmacovigilance team.


The ideal candidate will have extensive experience within safety – predominantly within Signal Management and Risk Minimization. This role will be very hands on, and therefore a proven background in authoring or preparing PBRERs/DSURs and RMPs would be a distinct advantage for this position.


The successful candidate will be experienced in providing expert safety input into clinical development projects, Risk Management as well as working with potential drug related risks and serious adverse events.


Experience required:

  • Strong background in drug safety
  • Strong understand of PV / Regulatory guidelines
  • Masters degree in Pharmacy or equivalent
  • Hands on background in Risk Management / aggregate reports (PBRERs/DSURs)


A full briefing is available – please contact Ryan Winter for more details.


At RBW Consulting, every one of our consultants has in depth experience in helping Pharmaceutical Professionals find the jobs they are looking for in the industry. With unrivalled industry knowledge and excellent links with hiring managers in Biotechs, Pharmas and CROs throughout the UK, Europe and across the world, we would be delighted to speak with you about the role you are looking for.  Please call the RBW Consulting Switchboard (617 982 1238) and ask for Ryan Winter.


Salary: On application

Ryan Winter

Add to shortlist

Apply now


This website may use cookies to provide an improved experience. You can refuse these cookies by changing your browser settings.
To remove this message, click here to accept cookies.